F. Santé-publique, Bilans annuels. Les infections invasives à méningocoques en, 2015.

, French Ministry of Social Affairs and Health. Instruction DGS/ RI1/DUS/2014/301 du 24 octobre 2014 relative à la prophylaxie des infections invasives à méningocoque. [National recommendations and policy regarding prophylaxis of invasive meningococcal diseases

. Dgs/ri1/dus/, , 2014.

. French,

A. Perrocheau, Outbreak of group B meningococcal disease in France prompted community chemoprophylaxis, Euro Surveill, vol.4, issue.13, p.1631, 2000.

F. Caron, I. P. Du-châtelet, J. P. Leroy, C. Ruckly, M. Blanchard et al., From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak, Lancet Infect Dis, vol.11, issue.6, pp.455-63, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-02083160

E. Delisle, S. Larrieu, J. Simões, N. Laylle, D. Pommerol et al., Community outbreak of group B meningococcal disease in southwest France, Euro Surveill, vol.15, issue.37, p.20929645, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-02082943

F. Santé-publique, Calendrier des vaccinations et recommandations vaccinales 2016. [Vaccination schedule and vaccine recommendations, vol.20, 2016.

M. C. Maiden, J. A. Bygraves, E. Feil, G. Morelli, J. E. Russell et al., Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms, Proc Natl Acad Sci USA, vol.95, issue.6, p.9501229, 1998.

U. Vogel, M. K. Taha, J. A. Vazquez, J. Findlow, H. Claus et al., Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, Lancet Infect Dis, vol.13, issue.5, p.23414709, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02093031

E. Hong, A. Terrade, and M. K. Taha, Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine, Hum Vaccin Immunother, vol.13, issue.3, p.27808594, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01579663

I. Parent-du-chatelet, A. E. Deghmane, D. Antona, E. Hong, L. Fonteneau et al., Characteristics and changes in invasive meningococcal disease epidemiology in France, J Infect, vol.74, issue.6, p.28279715, 2006.
URL : https://hal.archives-ouvertes.fr/pasteur-02013252

D. M. Hill, J. Lucidarme, S. J. Gray, L. S. Newbold, R. Ure et al., Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study, Lancet Infect Dis, vol.15, issue.12, pp.1420-1428, 2015.

. Haut-conseil-de-la-santé-publique, Avis relatif à l'utilisation du vaccin Bexsero

. Paris, Haut conseil de la santé Publique, vol.25, 2013.

P. S. Watson and D. P. Turner, Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease, Vaccine, vol.34, issue.7, p.26686570, 2016.

M. A. Botrel, L. Fonteneau, M. Boussac-zarebska, P. Du-chatelet, I. Guthmann et al., Estimation des couvertures vaccinales à partir des données de l'Assurance maladie. Exemple de la vaccination contre le meningocoque C

;. Paris and F. Santé-publique, , 2015.

, Analysis of vaccine coverage during a preventive vaccination campaign against meningococcus C, 2002.

, Etude de la couverture vaccinale suite à la campagne de vaccination contre le méningocoque C dans les Landes, les Pyrénées Atlantiques et les Hautes Pyrénées en, 2002.

C. Renaudat, S. Aboukaïs, P. Grenier-tisserand, A. Armengaud, F. Franke et al., Évaluation des couvertures vaccinales et des campagnes de vaccination contre le méningocoque C dans la vallée de Barcelonnette, Alpes de Haute-Provence, janvier-février 2007. [Evaluation of the vaccination coverage and the vaccination campaigns against meningococcus C in, 2007.